Back to Department of Neurology
Neurology Research
Explore & Expand the Science of Neurology
Delve deeper into disorders of the nervous system with world-renowned research programs changing what we know about these diseases and the lives of those affected.
Where Research Changes Lives
The U-M Medical School Department of Neurology research programs span the spectrum of neurosciences. Explore basic studies in the pathogenesis of disease, the identification of conditions, patient-oriented disease phenotype studies, the response to novel treatments, epidemiology and health services research related to neurologic disease.
Research Strengths
Learn more about our research strengths across all our divisions of Neurology science.
Michigan Alzheimer’s Disease Center
We are home to a multi-disciplinary campus-wide effort working toward a better understanding of, and an intervention for, Alzheimer's disease and related dementias.
Neurology Research By the Numbers
200+
Annual Articles in Peer-Reviewed Journals
9th
Nationally in Receiving NIH Funding
Featured News & Stories
Health Lab
Who gets Alzheimer’s drugs? Race, vulnerability and health status shape access
A Michigan Medicine study found major disparities in access to new Alzheimer’s drugs, with Black and Hispanic patients less likely to receive treatment, though adherence was similar once therapy began.
Department News
Who gets Alzheimer's drugs? Race, vulnerability and health status shape access
The findings, published in Neurology, highlight potential disparities in access to a new class of Alzheimer's treatments as use of these therapies increases.
Department News
Where Sleep Medicine Is Heading After SLEEP 2026: Anita Shelgikar, MD, MHPE
Dr. Shelgikar, professor of neurology at the University of Michigan Medical School discussed the themes that defined SLEEP 2026, and what they signal for clinical practice heading into 2027
Minding Memory
Can Your Voice Reveal Early Signs of Alzheimer’s?
In this episode, Lauren & Matt speak with Neguine Rezaii, MD, an Assistant Professor of Neurology at Harvard Medical School and a Board-Certified Neuropsychiatrist at Mass General Hospital. Dr. Rezaii’s research focuses on using natural language processing and artificial intelligence to improve the detection and classification of neurodegenerative disorders.
Dr. Rezaii talks about her recent study, “Voiceprints of Cognitive Impairment: Analyzing Digital Voice for Early Detection of Alzheimer’s and Related Dementias,” which explores how artificial intelligence can analyze short speech samples to identify subtle signs of cognitive impairment. The study used speech recordings from 120 individuals and found that features such as pauses, word choice and the specificity of language can help distinguish cognitive impairment and Alzheimer’s disease.
The conversation also explores how a simple 30-second speech test could potentially be used in clinical settings to support earlier detection and monitoring of cognitive impairment, as well as the challenges and ethical considerations that come with using AI to analyze something as personal as a person’s voice.
Philanthropy News
A pediatric epilepsy fundraiser that changes lives
Your support of Calming the Storm advances pediatric epilepsy research and patient care programs. There are many ways you can contribute to make a difference for so many children and families.
Department News
New blood tests offer another tool to detect Alzheimer’s early
Alzheimer's disease can be hard to pin down early-on. But a new generation of blood tests is giving doctors another way to look for it.
